Relation between adverse events associated with allopurinol and renal function in patients with gout

Annals of the Rheumatic Diseases

Volumn 60, Issue 10, 2001, Pages 981-983

  Vazquez Mellado J ^a   Meono Morales E ^a   Pacheco Tena, C ^a   Burgos Vargas, R ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL;

ADULT; AGED; ARTICLE; CREATININE CLEARANCE; FEMALE; GOUT; HUMAN; HYPERSENSITIVITY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; URIC ACID BLOOD LEVEL; VASCULITIS;

ADULT; AGED; ALLOPURINOL; CREATININE; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0034827359     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.10.981     Document Type: Article

References (16)

1. Use and abuse of allopurinol
2. Allopurinol hypersensitivity syndrome: A review
3. Allopurinol hepatotoxicity
4. Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis
5. Acute adverse reactions attributed to allopurinol in hospitalised patients
6. Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol
7. Severe allopurinol toxicity
8. The management of gout
9. Hyperuricemia and gout
10. Dosage adjustments of drugs in renal failure
11. Management of hyperuricemia
12. Desensitization to allopurinol after allopurinol hypersensitivity syndrome with renal involvement in gout. Case report
13. Evaluation of a thiazide-allopurinol drug interaction
14. The allopurinol hypersensitivity syndrome
15. Desensitisation to allopurinol in- patients with gout and cutaneous reactions
16. Efficacy of allopurinol and benzobromarone for the control of hyperuricemia. A pathogenic approach to the treatment of primary chronic gout